Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
Abstract Proprotein convertase subtilisin/kexin type 9 (PCSK9) has evolved as a pivotal enzyme in lipid metabolism and a revolutionary therapeutic target for hypercholesterolemia and its related cardiovascular diseases (CVD). This comprehensive review delineates the intricate roles and wide-ranging...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2024-01-01
|
| coleção: | Signal Transduction and Targeted Therapy |
| Acesso em linha: | https://doi.org/10.1038/s41392-023-01690-3 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|